New insights into sudden cardiac arrest revealed

21 January 2015

Bioscience researchers at the University of Kent have published new research detailing the mechanics of hypertrophic cardiomyopathy on a molecular level.

The study focuses on how heart muscles are controlled by calcium in greater depth than previous research. It is hoped that this new level of understanding can lead to treatment of the condition’s underlying causes, rather than waiting for dangerous symptoms to present themselves.

It was discovered that two myosin motors within the muscle are needed to turn on a regulatory unit made up of a further 11 of these motors, which communicate via thin protein filaments. The researchers have also furthered their understanding of precisely how these components interact with each other.

Despite its alarming symptoms, hypertrophic cardiomyopathy affects approximately one in 500 of the population. It recently came to prominence in the media when footballer Fabrice Muamba suffered a cardiac arrest during a match in March 2012.
The study will be published in the Journal of Biological Chemistry on January 23rd.

Posted by ​Phillip Briggs 


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)